المؤلفون: Kenneally AM; Pharmacy Department, Riley Hospital for Children, Indianapolis, Indiana., Bates BN; Pharmacy Department, Indiana University Health, Indianapolis, Indiana.

المصدر: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2024 Jun 01; Vol. 43 (6), pp. e220. Date of Electronic Publication: 2024 Feb 06.

نوع المنشور: Case Reports; Review; Letter; Journal Article

بيانات الدورية: Publisher: Williams & Wilkins Country of Publication: United States NLM ID: 8701858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-0987 (Electronic) Linking ISSN: 08913668 NLM ISO Abbreviation: Pediatr Infect Dis J Subsets: MEDLINE

مواضيع طبية MeSH: Raltegravir Potassium*/therapeutic use , Drug Overdose*, Humans ; Infant, Newborn ; HIV Infections/drug therapy ; Anti-HIV Agents/adverse effects ; Anti-HIV Agents/therapeutic use ; Male ; Female ; Pyrrolidinones

المؤلفون: West RE 3rd; Center for Clinical Pharmaceutical Sciences, Department of Pharmacy & Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA., Oberly PJ; Center for Clinical Pharmaceutical Sciences, Department of Pharmacy & Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA., Saylor AJ; Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Riddler SA; Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Nolin TD; Center for Clinical Pharmaceutical Sciences, Department of Pharmacy & Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA., Devanathan AS; Center for Clinical Pharmaceutical Sciences, Department of Pharmacy & Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: asd129@pitt.edu.

المصدر: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2024 Jul 01; Vol. 1241, pp. 124164. Date of Electronic Publication: 2024 May 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101139554 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-376X (Electronic) Linking ISSN: 15700232 NLM ISO Abbreviation: J Chromatogr B Analyt Technol Biomed Life Sci Subsets: MEDLINE

مواضيع طبية MeSH: Tandem Mass Spectrometry*/methods , Drug Monitoring*/methods , Heterocyclic Compounds, 3-Ring*/analysis , Heterocyclic Compounds, 3-Ring*/pharmacokinetics , Heterocyclic Compounds, 3-Ring*/therapeutic use , Heterocyclic Compounds, 3-Ring*/blood , Pyridones*/analysis , Pyridones*/blood , Piperazines*/analysis , Piperazines*/blood, Humans ; Chromatography, High Pressure Liquid/methods ; Reproducibility of Results ; Limit of Detection ; Linear Models ; Female ; Oxazines/chemistry ; Raltegravir Potassium/analysis ; Raltegravir Potassium/therapeutic use ; Triazoles/analysis ; Triazoles/blood ; Heterocyclic Compounds, 4 or More Rings/analysis ; Heterocyclic Compounds, 4 or More Rings/pharmacokinetics ; Heterocyclic Compounds, 4 or More Rings/blood ; Pyridazines/analysis ; Pyridazines/pharmacokinetics ; Anti-Retroviral Agents/analysis ; Anti-Retroviral Agents/pharmacokinetics ; Anti-Retroviral Agents/blood ; Anti-Retroviral Agents/therapeutic use ; Pyridines/analysis ; Pyridines/blood ; Pyridines/pharmacokinetics ; Pyridines/therapeutic use ; Cervix Uteri/chemistry ; HIV Infections/drug therapy ; Amides ; Diketopiperazines

المؤلفون: Eholie SP; Université Félix Houphouët-Boigny, Département de Dermatologie et d'Infectiologie, UFR des Sciences Médicales, Abidjan, Côte d'Ivoire; Centre Hospitalier Universitaire de Treichville Service des Maladies Infectieuses et Tropicales, Abidjan, Côte d'Ivoire; Programme PACCI, Abidjan, Côte d'Ivoire., Ekouevi DK; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France; Centre Africain de Recherche en Epidémiologie et en Santé Publique, Lomé, Togo; Université de Lomé, Département Santé Publique, Lomé, Togo., Chazallon C; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France., Charpentier C; Service de virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France., Messou E; Centre de Prise en Charge et de Formation (CePReF), Abidjan, Côte d'Ivoire., Diallo Z; Université Félix Houphouët-Boigny, Département de Dermatologie et d'Infectiologie, UFR des Sciences Médicales, Abidjan, Côte d'Ivoire; Centre Hospitalier Universitaire de Treichville Service des Maladies Infectieuses et Tropicales, Abidjan, Côte d'Ivoire; Programme PACCI, Abidjan, Côte d'Ivoire., Zoungrana J; Service des Maladies Infectieuses et Tropicales, CHU Sourô Sanou, Bobo-Dioulasso, Burkina-Faso., Minga A; Centre Médical de Suivi des Donneurs de Sang (CMSDS-CNTSCI), Abidjan, Côte d'Ivoire., Ngom Gueye NF; Service des Maladies Infectieuses et Tropicales, CHNU Fann, Dakar, Sénégal., Hawerlander D; Centre Intégré de Recherches Biocliniques d'Abidjan (CIRBA) Abidjan, Côte d'Ivoire., Dembele F; Unité de soins ambulatoires et de conseil (USAC), CHU de Treichville, Abidjan, Côte d'Ivoire., Colin G; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France., Tchounga B; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France., Karcher S; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France., Le Carrou J; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France., Tchabert-Guié A; Programme PACCI, Abidjan, Côte d'Ivoire., Toni TD; Programme PACCI, Abidjan, Côte d'Ivoire; CeDReS, Centre Hospitalier Universitaire de Treichville, Abidjan, Côte d'Ivoire., Ouédraogo AS; Unité de Virologie, CHU Sourô Sanou, Bobo-Dioulasso, Burkina-Faso., Bado G; Unité de Virologie, CHU Sourô Sanou, Bobo-Dioulasso, Burkina-Faso., Toure Kane C; Laboratoire de Bacteriologie, Virologie, CHU Le Dantec, Dakar, Sénégal., Seydi M; Service des Maladies Infectieuses et Tropicales, CHNU Fann, Dakar, Sénégal., Poda A; Service des Maladies Infectieuses et Tropicales, CHU Sourô Sanou, Bobo-Dioulasso, Burkina-Faso., Mensah E; ONG espoir Vie Togo, Cente Medico-social, Licia Lomé, Togo., Diallo I; Service de Médecine Interne, CHU Yalgado OUEDRAOGO, Ouagadougou, Burkina Faso., Drabo YJ; Service de Médecine Interne, CHU Yalgado OUEDRAOGO, Ouagadougou, Burkina Faso., Anglaret X; Programme PACCI, Abidjan, Côte d'Ivoire; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, Bordeaux, France. Electronic address: xavier.anglaret@u-bordeaux.fr., Brun-Vezinet F; Service de virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.

مؤلفون مشاركون: FIT-2 study group

المصدر: The lancet. HIV [Lancet HIV] 2024 Jun; Vol. 11 (6), pp. e380-e388. Date of Electronic Publication: 2024 May 10.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/drug therapy , HIV-2*/drug effects , Tenofovir*/therapeutic use , Tenofovir*/adverse effects , Emtricitabine*/therapeutic use , Emtricitabine*/administration & dosage , Emtricitabine*/adverse effects , Anti-HIV Agents*/therapeutic use , Anti-HIV Agents*/adverse effects , Anti-HIV Agents*/administration & dosage , Ritonavir*/therapeutic use , Ritonavir*/administration & dosage , Ritonavir*/adverse effects, Humans ; Adult ; Male ; Female ; Pilot Projects ; CD4 Lymphocyte Count ; Treatment Outcome ; Lopinavir/therapeutic use ; Lopinavir/adverse effects ; Lopinavir/administration & dosage ; Raltegravir Potassium/therapeutic use ; Raltegravir Potassium/adverse effects ; Raltegravir Potassium/administration & dosage ; Lamivudine/therapeutic use ; Lamivudine/administration & dosage ; Lamivudine/adverse effects ; Viral Load/drug effects ; Antiretroviral Therapy, Highly Active ; Middle Aged ; Zidovudine/therapeutic use ; Zidovudine/adverse effects ; Zidovudine/administration & dosage ; Drug Therapy, Combination ; HIV-1/drug effects

المؤلفون: Ludna Duarte M; Department of Pharmaceutical Sciences, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil. Electronic address: mairaludna@gmail.com., Mikaelle Brandão Silva A; Department of Pharmaceutical Sciences, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil., Wellithom Viturino da Silva J; Department of Pharmaceutical Sciences, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil., Pereira Santana D; Department of Pharmaceutical Sciences, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil. Electronic address: davi.santana@nudfac.com.br., Victor de Castro W; Graduate Program in Pharmaceutical Sciences, Federal University of São João del-Rei, Av. Sebastião Gonçalves Coelho 400, Chanadour, Divinópolis, Minas Gerais, CEP 35501-296, Brazil. Electronic address: whocely@ufsj.edu.br., Cláudio Arraes de Alencar L; Department of Tropical Medicine, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil., César Galindo Bedor D; Department of Pharmaceutical Sciences, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil. Electronic address: danilo.bedor@nudfac.com.br., Bastos Leal L; Department of Pharmaceutical Sciences, Federal University of Pernambuco, Campus Recife, S/n, Recife, Pernambuco, CEP 50740-521, Brazil. Electronic address: leila.leal@nudfac.com.br.

المصدر: Clinical biochemistry [Clin Biochem] 2024 May; Vol. 127-128, pp. 110765. Date of Electronic Publication: 2024 Apr 20.

نوع المنشور: Journal Article; Validation Study

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0133660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2933 (Electronic) Linking ISSN: 00099120 NLM ISO Abbreviation: Clin Biochem Subsets: MEDLINE

مواضيع طبية MeSH: Benzoxazines*/blood , Benzoxazines*/pharmacokinetics , Benzoxazines*/therapeutic use , Cyclopropanes*/blood , Alkynes* , Tandem Mass Spectrometry*/methods , Drug Monitoring*/methods , Dried Blood Spot Testing*/methods , HIV Infections*/drug therapy , HIV Infections*/blood, Humans ; Female ; Pregnancy ; Atazanavir Sulfate/blood ; Atazanavir Sulfate/therapeutic use ; Atazanavir Sulfate/pharmacokinetics ; Ritonavir/blood ; Ritonavir/therapeutic use ; Chromatography, Liquid/methods ; Pregnancy Complications, Infectious/drug therapy ; Pregnancy Complications, Infectious/blood ; Raltegravir Potassium/blood ; Raltegravir Potassium/therapeutic use ; Anti-HIV Agents/blood ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/pharmacokinetics ; Liquid Chromatography-Mass Spectrometry

المؤلفون: Brkić-Jovanović N; Department of Psychology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia., Karaman M; Department of Psychology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia., Andrić V; Department of Infectious Diseases, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia., Marić D; Department of Infectious Diseases, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia., Brkić S; Department of Infectious Diseases, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia., Bugarski-Ignjatović V; Department of Psychology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.

المصدر: PloS one [PLoS One] 2024 Jun 26; Vol. 19 (6), pp. e0306278. Date of Electronic Publication: 2024 Jun 26 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/drug therapy , HIV Infections*/psychology , HIV Infections*/complications , Cognition*, Humans ; Male ; Adult ; Follow-Up Studies ; Raltegravir Potassium/therapeutic use ; HIV Integrase Inhibitors/therapeutic use ; Middle Aged ; Pyridones/therapeutic use ; Piperazines/therapeutic use ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Oxazines/therapeutic use ; Neuropsychological Tests ; HIV-1

المؤلفون: Hitl M; Department of Pharmacy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.; Center for Medical and Pharmaceutical Investigations and Quality Control, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia., Pavlović N; Department of Pharmacy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.; Center for Medical and Pharmaceutical Investigations and Quality Control, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia., Brkić S; Department of Infectious Diseases, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.; Clinic for Infectious Diseases, Clinical Centre of Vojvodina, 21000 Novi Sad, Serbia., Dragović G; Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia., Srđenović-Čonić B; Department of Pharmacy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.; Center for Medical and Pharmaceutical Investigations and Quality Control, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia., Kladar N; Department of Pharmacy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.; Center for Medical and Pharmaceutical Investigations and Quality Control, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 13; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/drug therapy , Anti-HIV Agents*/therapeutic use , Alkynes* , Cyclopropanes* , Benzoxazines*, Humans ; Raltegravir Potassium/therapeutic use ; Darunavir/pharmacokinetics ; Darunavir/therapeutic use ; Rosmarinic Acid ; Anti-Retroviral Agents/therapeutic use

عنوان ترانسليتريتد: Resistencia a los inhibidores de la integrasa en niños con el virus de la inmunodeficiencia humana por transmisión vertical: primeros casos en Uruguay.

المؤلفون: González Castro AV; Clínica Pediátrica; Facultad de Medicina, Universidad de la República, Uruguay., Sande V; Clínica Pediátrica; Facultad de Medicina, Universidad de la República, Uruguay., Pardo Casaretto LV; Clínica Pediátrica; Facultad de Medicina, Universidad de la República, Uruguay.; Departamento de Bacteriología y Virología; Facultad de Medicina, Universidad de la República, Uruguay., Gutiérrez Rodríguez SI; Clínica Pediátrica; Facultad de Medicina, Universidad de la República, Uruguay.

المصدر: Archivos argentinos de pediatria [Arch Argent Pediatr] 2024 Feb 01; Vol. 122 (1), pp. e202302992. Date of Electronic Publication: 2023 Jun 01.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Sociedad Argentina de Pediatría Country of Publication: Argentina NLM ID: 0372460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1668-3501 (Electronic) Linking ISSN: 03250075 NLM ISO Abbreviation: Arch Argent Pediatr Subsets: MEDLINE

مواضيع طبية MeSH: HIV Integrase Inhibitors*/therapeutic use , HIV Integrase Inhibitors*/pharmacology , HIV-1*/genetics , HIV Infections*/drug therapy , Anti-HIV Agents*/therapeutic use, Humans ; Child ; Uruguay ; Raltegravir Potassium/pharmacology ; Raltegravir Potassium/therapeutic use ; Mutation

المؤلفون: Mahajan PS; Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, United States., Smith SJ; Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, United States., Li M; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States., Craigie R; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States., Hughes SH; HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, United States., Zhao XZ; Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, United States., Burke TR Jr; Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, United States.

المصدر: ACS infectious diseases [ACS Infect Dis] 2024 Mar 08; Vol. 10 (3), pp. 917-927. Date of Electronic Publication: 2024 Feb 12.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: HIV Integrase Inhibitors*/pharmacology , HIV Integrase*/genetics, Raltegravir Potassium/pharmacology ; Pyridones/pharmacology

المؤلفون: Hikichi Y; Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA., Grover JR; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA., Schäfer A; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA., Mothes W; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA., Freed EO; Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.

المصدر: Science advances [Sci Adv] 2024 Mar; Vol. 10 (9), pp. eadn0042. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

مواضيع طبية MeSH: HIV Integrase Inhibitors*/pharmacology , HIV-1*/genetics , HIV-1*/metabolism , HIV Integrase*/genetics , HIV Integrase*/metabolism, Humans ; Raltegravir Potassium/pharmacology ; Mutation

المؤلفون: Borjabad B; Internal Medicine Service, Hospital Moises Broggi, Sant Joan Despí, Spain., Inciarte A; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain., Chivite I; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain., Gonzalez-Cordon A; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Mosquera M; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Hurtado C; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain., Rovira C; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain., Gonzalez T; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain., Sempere A; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain., Torres B; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Calvo J; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain., De La Mora L; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Martinez-Rebollar M; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Laguno M; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Foncillas A; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain., Ambrosioni J; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Blanch J; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; Internal Medicine Service, Hospital Universitari de Santa Maria, Lleida, Spain.; CIBER de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain., Rodriguez A; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain., Solbes E; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain., Llobet R; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain., Berrocal L; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain., Mallolas J; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Miro JM; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Alcami J; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Acquired Immunodeficiency Syndrome (AIDS) Immunopathology Unit, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Spain., Blanco JL; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Sanchez-Palomino S; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., De Lazzari E; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Martinez E; Infectious Diseases Unit, Hospital Clínic, University of Barcelona 08036, Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

المصدر: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Feb 01; Vol. 79 (2), pp. 255-261.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/drug therapy , Anti-HIV Agents*/adverse effects , Drug-Related Side Effects and Adverse Reactions*, Humans ; Raltegravir Potassium/adverse effects ; Lamivudine/adverse effects ; Prospective Studies ; Quality of Life ; Drug Therapy, Combination ; Viral Load ; Treatment Outcome